Literature DB >> 6929198

Paget's disease of bone.

E S Siris, T P Jacobs, R E Canfield.   

Abstract

Mesh:

Year:  1980        PMID: 6929198      PMCID: PMC1805153     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN: 0028-7091


× No keyword cloud information.
  45 in total

1.  MITHRAMYCIN IN THE TREATMENT OF DISSEMINATED TESTICULAR NEOPLASMS.

Authors:  J H BROWN; B J KENNEDY
Journal:  N Engl J Med       Date:  1965-01-21       Impact factor: 91.245

2.  Evidence for linkage between HLA and Paget's disease.

Authors:  M Fotino; A Haymovits; C T Falk
Journal:  Transplant Proc       Date:  1977-12       Impact factor: 1.066

3.  Metabolic and toxic effects of mithramycin during tumor therapy.

Authors:  B J Kennedy
Journal:  Am J Med       Date:  1970-10       Impact factor: 4.965

4.  Treatment of Paget's disease with mithramycin: further experiences.

Authors:  W G Ryan; T B Schwartz; G Northrop
Journal:  Semin Drug Treat       Date:  1972

5.  Effects of synthetic salmon calcitonin in patients with Paget's disease of bone.

Authors:  C R Hamilton
Journal:  Am J Med       Date:  1974-03       Impact factor: 4.965

6.  The treatment of Paget's disease of bone by radiotherapy.

Authors:  V Levison
Journal:  Ann Phys Med       Date:  1970-02

7.  Effects of mithramycin on Paget's disease of bone.

Authors:  W G Ryan; T B Schwartz; C P Perlia
Journal:  Ann Intern Med       Date:  1969-03       Impact factor: 25.391

8.  Paget's bone disease treated with diphosphonate and calcitonin.

Authors:  D J Hosking; O L Bijvoet; J van Aken; E J Will
Journal:  Lancet       Date:  1976-03-20       Impact factor: 79.321

9.  Mithramycin therapy in Paget's disease.

Authors:  A S Russell; B C Lentle
Journal:  Can Med Assoc J       Date:  1974-02-16       Impact factor: 8.262

10.  Giant cell tumor in Paget's disease of bone: familial and geographic clustering.

Authors:  T P Jacobs; J Michelsen; J S Polay; A C D'Adamo; R E Canfield
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

View more
  5 in total

1.  European origin of patients with Paget's disease of bone in the Buenos Aires area.

Authors:  C Gómez Acotto; C A Mautalen
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 2.  Pathobiology of Paget's Disease of Bone.

Authors:  Deborah L Galson; G David Roodman
Journal:  J Bone Metab       Date:  2014-05-31

Review 3.  Current options for the treatment of Paget's disease of the bone.

Authors:  Daniela Merlotti; Luigi Gennari; Giuseppe Martini; Ranuccio Nuti
Journal:  Open Access Rheumatol       Date:  2009-07-17

4.  Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62P394L mouse model of Paget's disease.

Authors:  Anna Daroszewska; Lorraine Rose; Nadine Sarsam; Gemma Charlesworth; Amanda Prior; Kenneth Rose; Stuart H Ralston; Robert J van 't Hof
Journal:  Dis Model Mech       Date:  2018-08-23       Impact factor: 5.758

5.  Monostotic Paget Disease of the Lumbar Vertebrae: A Pathological Mimicker.

Authors:  Vishnu Senthil; Satish Balaji
Journal:  Neurospine       Date:  2018-06-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.